Inflammatory Markers Predicting Pathological Complete Response in Cases with Breast Cancer Treated by Neoadjuvant Chemotherapy

Buyuksimsek M., Ogul A., Mirilli C., PAYDAŞ S.

EUROPEAN JOURNAL OF BREAST HEALTH, vol.16, no.4, pp.229-234, 2020 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 16 Issue: 4
  • Publication Date: 2020
  • Doi Number: 10.5152/ejbh.2020.5556
  • Journal Name: EUROPEAN JOURNAL OF BREAST HEALTH
  • Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Page Numbers: pp.229-234
  • Keywords: Breast cancer, dNLR, MHR, NLR, PNI, PROGNOSTIC NUTRITIONAL INDEX, SURGICAL ADJUVANT BREAST, LYMPHOCYTE RATIO, NEUTROPHIL, SURVIVAL, THERAPY, RECOMMENDATIONS, BIOMARKERS, RECEPTORS, CARCINOMA
  • Çukurova University Affiliated: Yes

Abstract

Objective: Response to neoadjuvant chemotherapy (NAC) is predictive for survival times in some patients with breast cancer (BC). The aim of this study is to explore the predictive value of some inflammatory markers including neutrophil-to-lymphocyte ratio (NLR), derived neutrophilto-lymphocyte ratio (dNLR), monocyte-to-high density lipoprotein ratio (MHR) and prognostic nutritional index (PNI) in cases with BC treated with NAC.